BRILINTA®
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.brilintahcp.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About BRILINTA®
BRILINTA® (ticagrelor) is an oral prescription medication aimed at reducing the risk of cardiovascular death, myocardial infarction, and stroke in patients with acute coronary syndrome (ACS), a history of myocardial infarction, and high-risk coronary artery disease (CAD). It is particularly indicated for patients with acute ischemic stroke or high-risk transient ischemic attack (TIA). The product is positioned for healthcare professionals (HCPs) and offers resources for patient education and affordability options. BRILINTA has been shown to be superior to clopidogrel in efficacy for at least the first 12 months following ACS.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BRILINTA® your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on BRILINTA® recently announced quarterly report
Funding: Get notified immidiatlly once BRILINTA® has new funding data
Congratulate Masked Content for being promoted to Masked Content at BRILINTA®
Check out if BRILINTA® is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when BRILINTA® launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if BRILINTA® has recently received funding, and reach out quickly before it becomes old news!
BRILINTA®, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if BRILINTA® had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to BRILINTA®
Compare insights from companies similar to BRILINTA®, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
BRILINTA®
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
BRILINTA® is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
BRILINTA® is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about BRILINTA®.
BRILINTA® Tech Stack
A closer look at the technologies used by BRILINTA®
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BRILINTA®
Sign Up For FreeTo access detailed company insights
BRILINTA® (ticagrelor) is an oral prescription medication aimed at reducing the risk of cardiovascular death, myocardial infarction, and stroke in patients with acute coronary syndrome (ACS), a history of myocardial infarction, and high-risk coronary artery disease (CAD). It is particularly indicated for patients with acute ischemic stroke or high-... Read More
